TIGAR and pancreatic ductal adenocarcinoma: Notably, although one study has reported that TIGAR deficiency promotes activation of ERK signaling, another major subfamily of MAPK, and thus supports the invasive capacity of pancreatic ductal adenocarcinoma cells [45], the relationship between TIGAR and P38 MAPK signaling pathway has not yet been established.